MicroCHIPS completes first human trial of the company’s pharmacy on a chip technology used for the subcutaneous delivery of drugs to chronic patients.
Tag: David H. Koch Institute for Integrative Cancer Research
MicroCHIPS completes first human trial of the company’s pharmacy on a chip technology used for the subcutaneous delivery of drugs to chronic patients.
Join our mailing list to receive the latest news and updates from our team.